13th Biosimilars Congregation 2019

Date : 11th June 2019 to 12th June 2019

Place : United Kingdom, London

Website :https://www.virtueinsight.com/pharma/13th-Biosimilars-Congregation-2019/

Contact Person:kavitha

Description:

13th Biosimilars Congregation 2019 will provide insight into the current state of play in the EU and stimulate debate, in a multi-stakeholder setting, on the vital role of biosimilar medicines in the sustainability of healthcare systems. Beyond a comprehensive outlook of key European market access policies, our speakers will outline the key recent developments in regulatory science and regulatory policy in the EU and other international jurisdictions. Special emphasis will be placed on strengthening the link between regulators and medical communities as an essential basis for greater understanding and acceptance of biosimilar medicines. This Biosimilars conference will focus on multiple aspects of Biosimilar product development to successfully deliver safe, Biosimilar products to the market place. By attending this conference, you will gain a comprehensive outlook on the key issues surrounding Biosimilars. This event will provide an important platform for Biosimilars stakeholders to discuss and share best practices in furthering Biosimilars development.CONFERENCE SPONSORSHIP: Email: [email protected] or Tel: +44 2036120886 Sponsor, Exhibition Stall (Booth) and a paid Speaker Slots are also available We also have some sponsorship opportunities available for the event, which gives you an opportunity to sponsor/speak/exhibit, and create brand awareness. In addition, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts. CONFERENCE REGISTRATION: In order to Register please let us know your interests through Email: [email protected] or Tel: +44 2036120886 • Introductory Offer - 3 delegate places for the price of 2 - A huge saving of £750 - (Limited seats left) • Super Early Discount (Valid Till 1st April 2019): (£750 + VAT per delegate) • Early Discount (2nd April 2019 - 12th May 2019): (£950 + VAT per delegate) • Standard Registration (13th May 2019 Onwards): (£1150 + VAT per delegate) CONFERENCE SPONSORSHIP: Email: [email protected] or Tel: +44 2036120886 Sponsor, Exhibition Stall (Booth) and a paid Speaker Slots are also available We also have some sponsorship opportunities available for the event, which gives you an opportunity to sponsor/speak/exhibit, and create brand awareness. In addition, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts. CONFERENCE REGISTRATION: In order to Register please let us know your interests through Email: [email protected] or Tel: +44 2036120886 • Introductory Offer - 3 delegate places for the price of 2 - A huge saving of £750 - (Limited seats left) • Super Early Discount (Valid Till 1st April 2019): (£750 + VAT per delegate) • Early Discount (2nd April 2019 - 12th May 2019): (£950 + VAT per delegate) • Standard Registration (13th May 2019 Onwards): (£1150 + VAT per delegate) Get more from the event, enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.

13th Biosimilars Congregation 2019 will be held in London,United Kingdom on date 2019-06-12

---

Deadline for abstracts/proposals : 10th June 2019

Keynote Speakers : • SUE NAEYAERT, Global Head Government Affairs, Policy & Pharmaceconomics, Fresenius Kabi SwissBioSim • SHU-YI SU, Statistical Scientist, Novartis • IAN HENSHAW, VP, Global Head of Biosimilar Business Unit, Biogen • MAGNUS BODIN, Director, Market Access Biosimilars, Biogen • CHRISTIAN AGBOTON, Sr Global Brand Medical Director - Global Medical Affairs, Takeda • JOSEPH DUNFORD, European Biosimilar Franchise Manager, Accord Healthcare • VICTOR SASTRE, Senior MSL , Amgen Bios

Conference Highlights :• Strategies for market access and expansion by identifying key changes and future projections • Consequences of Brexit on Biosimilars • Current Challenges and Opportunities for future- Strategies in developing Biosimilars • A Clinician ́s Guide to Biosimilars in Oncology: understanding the Science of Extrapolation and Interchangeability • Biosimilars – Pricing & Market access - Bringing it faster into market • GMP, GCP, QC & R&D • Current challenges and opport

Venue :Pestana Chelsea Bridge Hotel & SPA, Queenstown Road, London, UK

Check the event website for more details.